Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;2(2):86-8.
doi: 10.4103/0974-7753.77511.

Bimatoprost in the treatment of eyelash universalis alopecia areata

Teresa Ojeda Vila  1 , Francisco M Camacho Martinez
Affiliations

Bimatoprost in the treatment of eyelash universalis alopecia areata

Teresa Ojeda Vila et al. Int J Trichology. 2010 Jul.

Abstract

Objectives: To evaluate topical bimatoprost for eyelash growth in patients with alopecia areata (AA).

Design: A 1-year retrospective study, bilateral eyelash alopecia.

Materials and methods: Forty-one subjects with AA universalis without ocular disease applied 0.03% bimatoprost to the eyelid margin once a day over the course of 1 year.

Results: Thirty-seven subjects completed the study, one patient was eliminated due to conjunctivitis at the beginning of treatment, two patients developed conjunctivitis after 6 months of treatment, and a fourth did not follow directions. Researchers evaluated patients' eyelash growth every 4 months. We observed complete growth in 24.32%, moderate growth in 18.91%, slight growth in 27.02% and without response in 29.72%.

Conclusion: Bimatoprost may be effective and safe in the treatment of eyelash AA. 43.24% of the patients had an acceptable cosmetic response (total and moderate growth).

Limitations: Design without control.

Keywords: Alopecia areata; bimatoprost; eyelash growth; prostaglandins.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Responses to bimatoprost 0.03%
Figure 2
Figure 2
Moderate regrowth after 1 year of using bimatoprost
Figure 3
Figure 3
Moderate regrowth after 8 months of treatment with bimatoprost
Figure 4
Figure 4
Recurrence during the treatment
See this image and copyright information in PMC

References

    1. Johnstone MA. Hypertrichosis and increased pigmentation of eyelash and adjacent hair in the región of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol. 1997;124:544–7. - PubMed
    1. Woodward JA, Haggerty CJ, Stinnett SS, Williams ZY. Bimatoprost 0.03% gel for cosmetic eyelash growth and enhancement. J Cosmet Dermatol. 2010;9:96–102. - PubMed
    1. Sarifakioglu E, Degim IT, Gorpelioglu C. Determination of the sildenafil effect on the alopecia areata in childhood: An open-pilot comparison study. J Dermatolog Treat. 2006;17:235–7. - PubMed
    1. Coronel-Pérez IM, Rodréguez-Rey EM, Camacho-Marténez FM. Latanoprost in the treatment of eyelashes alopecia in alopecia areata universalis. J Eur Acad Dermatol Venereol. 2010;24:481–5. - PubMed
    1. Ochoa BE, Sah D, Wang G, Stamper R, Price VH. Instilled bimatoprost ophthalmic solution inpatients with eyelash alopecia areata. J Am Acad Dermatol. 2009;61:530–2. - PubMed